MovDisordV3, Main, Exploration, bibRecord, 000210

In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.

Identifieur interne : 000210 ( Main/Exploration ); précédent : 000209; suivant : 000211

In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.

Auteurs : Isaac M. Adanyeguh [France] ; Pierre-Gilles Henry ; Tra M. Nguyen ; Daisy Rinaldi ; Celine Jauffret ; Romain Valabregue ; Uzay E. Emir ; Dinesh K. Deelchand ; Alexis Brice ; Lynn E. Eberly ; Gülin Öz ; Alexandra Durr ; Fanny Mochel

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2015.

RBID : pubmed:25773989

Abstract

Spinocerebellar ataxias (SCAs) belong to polyglutamine repeat disorders and are characterized by a predominant atrophy of the cerebellum and the pons. Proton magnetic resonance spectroscopy ((1) H MRS) using an optimized semiadiabatic localization by adiabatic selective refocusing (semi-LASER) protocol was performed at 3 T to determine metabolite concentrations in the cerebellar vermis and pons of a cohort of patients with SCA1 (n=16), SCA2 (n=12), SCA3 (n=21), and SCA7 (n=12) and healthy controls (n=33). Compared with controls, patients displayed lower total N-acetylaspartate and, to a lesser extent, lower glutamate, reflecting neuronal loss/dysfunction, whereas the glial marker, myoinositol (myo-Ins), was elevated. Patients also showed higher total creatine as reported in Huntington's disease, another polyglutamine repeat disorder. A strong correlation was found between the Scale for the Assessment and Rating of Ataxia and the neurometabolites in both affected regions of patients. Principal component analyses confirmed that neuronal metabolites (total N-acetylaspartate and glutamate) were inversely correlated in the vermis and the pons to glial (myo-Ins) and energetic (total creatine) metabolites, as well as to disease severity (motor scales). Neurochemical plots with selected metabolites also allowed the separation of SCA2 and SCA3 from controls. The neurometabolic profiles detected in patients underlie cell-specific changes in neuronal and astrocytic compartments that cannot be assessed by other neuroimaging modalities. The inverse correlation between metabolites from these two compartments suggests a metabolic attempt to compensate for neuronal damage in SCAs. Because these biomarkers reflect dynamic aspects of cellular metabolism, they are good candidates for proof-of-concept therapeutic trials. © 2015 International Parkinson and Movement Disorder Society.

DOI: 10.1002/mds.26181
PubMed: 25773989

Affiliations:

France
Paris

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.</title>
<author><name sortKey="Adanyeguh, Isaac M" sort="Adanyeguh, Isaac M" uniqKey="Adanyeguh I" first="Isaac M" last="Adanyeguh">Isaac M. Adanyeguh</name>
<affiliation wicri:level="1"><nlm:affiliation>INSERM U 1127, Sorbonne Universités, UPMC Univ Paris Institut du Cerveau et de la Moelle épinière, ICM, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U 1127, Sorbonne Universités, UPMC Univ Paris Institut du Cerveau et de la Moelle épinière, ICM, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Henry, Pierre Gilles" sort="Henry, Pierre Gilles" uniqKey="Henry P" first="Pierre-Gilles" last="Henry">Pierre-Gilles Henry</name>
</author>
<author><name sortKey="Nguyen, Tra M" sort="Nguyen, Tra M" uniqKey="Nguyen T" first="Tra M" last="Nguyen">Tra M. Nguyen</name>
</author>
<author><name sortKey="Rinaldi, Daisy" sort="Rinaldi, Daisy" uniqKey="Rinaldi D" first="Daisy" last="Rinaldi">Daisy Rinaldi</name>
</author>
<author><name sortKey="Jauffret, Celine" sort="Jauffret, Celine" uniqKey="Jauffret C" first="Celine" last="Jauffret">Celine Jauffret</name>
</author>
<author><name sortKey="Valabregue, Romain" sort="Valabregue, Romain" uniqKey="Valabregue R" first="Romain" last="Valabregue">Romain Valabregue</name>
</author>
<author><name sortKey="Emir, Uzay E" sort="Emir, Uzay E" uniqKey="Emir U" first="Uzay E" last="Emir">Uzay E. Emir</name>
</author>
<author><name sortKey="Deelchand, Dinesh K" sort="Deelchand, Dinesh K" uniqKey="Deelchand D" first="Dinesh K" last="Deelchand">Dinesh K. Deelchand</name>
</author>
<author><name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
</author>
<author><name sortKey="Eberly, Lynn E" sort="Eberly, Lynn E" uniqKey="Eberly L" first="Lynn E" last="Eberly">Lynn E. Eberly</name>
</author>
<author><name sortKey="Oz, Gulin" sort="Oz, Gulin" uniqKey="Oz G" first="Gülin" last="Öz">Gülin Öz</name>
</author>
<author><name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Durr">Alexandra Durr</name>
</author>
<author><name sortKey="Mochel, Fanny" sort="Mochel, Fanny" uniqKey="Mochel F" first="Fanny" last="Mochel">Fanny Mochel</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25773989</idno>
<idno type="pmid">25773989</idno>
<idno type="doi">10.1002/mds.26181</idno>
<idno type="wicri:Area/PubMed/Corpus">000222</idno>
<idno type="wicri:Area/PubMed/Curation">000222</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000210</idno>
<idno type="wicri:Area/Ncbi/Merge">004296</idno>
<idno type="wicri:Area/Ncbi/Curation">004296</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004296</idno>
<idno type="wicri:Area/Main/Merge">000210</idno>
<idno type="wicri:Area/Main/Curation">000210</idno>
<idno type="wicri:Area/Main/Exploration">000210</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.</title>
<author><name sortKey="Adanyeguh, Isaac M" sort="Adanyeguh, Isaac M" uniqKey="Adanyeguh I" first="Isaac M" last="Adanyeguh">Isaac M. Adanyeguh</name>
<affiliation wicri:level="1"><nlm:affiliation>INSERM U 1127, Sorbonne Universités, UPMC Univ Paris Institut du Cerveau et de la Moelle épinière, ICM, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U 1127, Sorbonne Universités, UPMC Univ Paris Institut du Cerveau et de la Moelle épinière, ICM, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Henry, Pierre Gilles" sort="Henry, Pierre Gilles" uniqKey="Henry P" first="Pierre-Gilles" last="Henry">Pierre-Gilles Henry</name>
</author>
<author><name sortKey="Nguyen, Tra M" sort="Nguyen, Tra M" uniqKey="Nguyen T" first="Tra M" last="Nguyen">Tra M. Nguyen</name>
</author>
<author><name sortKey="Rinaldi, Daisy" sort="Rinaldi, Daisy" uniqKey="Rinaldi D" first="Daisy" last="Rinaldi">Daisy Rinaldi</name>
</author>
<author><name sortKey="Jauffret, Celine" sort="Jauffret, Celine" uniqKey="Jauffret C" first="Celine" last="Jauffret">Celine Jauffret</name>
</author>
<author><name sortKey="Valabregue, Romain" sort="Valabregue, Romain" uniqKey="Valabregue R" first="Romain" last="Valabregue">Romain Valabregue</name>
</author>
<author><name sortKey="Emir, Uzay E" sort="Emir, Uzay E" uniqKey="Emir U" first="Uzay E" last="Emir">Uzay E. Emir</name>
</author>
<author><name sortKey="Deelchand, Dinesh K" sort="Deelchand, Dinesh K" uniqKey="Deelchand D" first="Dinesh K" last="Deelchand">Dinesh K. Deelchand</name>
</author>
<author><name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
</author>
<author><name sortKey="Eberly, Lynn E" sort="Eberly, Lynn E" uniqKey="Eberly L" first="Lynn E" last="Eberly">Lynn E. Eberly</name>
</author>
<author><name sortKey="Oz, Gulin" sort="Oz, Gulin" uniqKey="Oz G" first="Gülin" last="Öz">Gülin Öz</name>
</author>
<author><name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Durr">Alexandra Durr</name>
</author>
<author><name sortKey="Mochel, Fanny" sort="Mochel, Fanny" uniqKey="Mochel F" first="Fanny" last="Mochel">Fanny Mochel</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Spinocerebellar ataxias (SCAs) belong to polyglutamine repeat disorders and are characterized by a predominant atrophy of the cerebellum and the pons. Proton magnetic resonance spectroscopy ((1) H MRS) using an optimized semiadiabatic localization by adiabatic selective refocusing (semi-LASER) protocol was performed at 3 T to determine metabolite concentrations in the cerebellar vermis and pons of a cohort of patients with SCA1 (n=16), SCA2 (n=12), SCA3 (n=21), and SCA7 (n=12) and healthy controls (n=33). Compared with controls, patients displayed lower total N-acetylaspartate and, to a lesser extent, lower glutamate, reflecting neuronal loss/dysfunction, whereas the glial marker, myoinositol (myo-Ins), was elevated. Patients also showed higher total creatine as reported in Huntington's disease, another polyglutamine repeat disorder. A strong correlation was found between the Scale for the Assessment and Rating of Ataxia and the neurometabolites in both affected regions of patients. Principal component analyses confirmed that neuronal metabolites (total N-acetylaspartate and glutamate) were inversely correlated in the vermis and the pons to glial (myo-Ins) and energetic (total creatine) metabolites, as well as to disease severity (motor scales). Neurochemical plots with selected metabolites also allowed the separation of SCA2 and SCA3 from controls. The neurometabolic profiles detected in patients underlie cell-specific changes in neuronal and astrocytic compartments that cannot be assessed by other neuroimaging modalities. The inverse correlation between metabolites from these two compartments suggests a metabolic attempt to compensate for neuronal damage in SCAs. Because these biomarkers reflect dynamic aspects of cellular metabolism, they are good candidates for proof-of-concept therapeutic trials. © 2015 International Parkinson and Movement Disorder Society.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<settlement><li>Paris</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
<name sortKey="Deelchand, Dinesh K" sort="Deelchand, Dinesh K" uniqKey="Deelchand D" first="Dinesh K" last="Deelchand">Dinesh K. Deelchand</name>
<name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Durr">Alexandra Durr</name>
<name sortKey="Eberly, Lynn E" sort="Eberly, Lynn E" uniqKey="Eberly L" first="Lynn E" last="Eberly">Lynn E. Eberly</name>
<name sortKey="Emir, Uzay E" sort="Emir, Uzay E" uniqKey="Emir U" first="Uzay E" last="Emir">Uzay E. Emir</name>
<name sortKey="Henry, Pierre Gilles" sort="Henry, Pierre Gilles" uniqKey="Henry P" first="Pierre-Gilles" last="Henry">Pierre-Gilles Henry</name>
<name sortKey="Jauffret, Celine" sort="Jauffret, Celine" uniqKey="Jauffret C" first="Celine" last="Jauffret">Celine Jauffret</name>
<name sortKey="Mochel, Fanny" sort="Mochel, Fanny" uniqKey="Mochel F" first="Fanny" last="Mochel">Fanny Mochel</name>
<name sortKey="Nguyen, Tra M" sort="Nguyen, Tra M" uniqKey="Nguyen T" first="Tra M" last="Nguyen">Tra M. Nguyen</name>
<name sortKey="Oz, Gulin" sort="Oz, Gulin" uniqKey="Oz G" first="Gülin" last="Öz">Gülin Öz</name>
<name sortKey="Rinaldi, Daisy" sort="Rinaldi, Daisy" uniqKey="Rinaldi D" first="Daisy" last="Rinaldi">Daisy Rinaldi</name>
<name sortKey="Valabregue, Romain" sort="Valabregue, Romain" uniqKey="Valabregue R" first="Romain" last="Valabregue">Romain Valabregue</name>
</noCountry>
<country name="France"><noRegion><name sortKey="Adanyeguh, Isaac M" sort="Adanyeguh, Isaac M" uniqKey="Adanyeguh I" first="Isaac M" last="Adanyeguh">Isaac M. Adanyeguh</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000210 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000210 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:25773989
   |texte=   In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:25773989" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.

In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.